Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma.
Pediatric sarcomas, including rhabdomyosarcomas, Ewing's sarcoma, and osteosarcoma, are aggressive tumors with poor survival rates. To overcome problems associated with nonselectivity of the current therapeutic approaches, targeted therapeutics have been developed. Currently, an increasing numb...
Main Authors: | Janne Nordberg, John Patrick Mpindi, Kristiina Iljin, Arto Tapio Pulliainen, Markku Kallajoki, Olli Kallioniemi, Klaus Elenius, Varpu Elenius |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23227212/?tool=EBI |
Similar Items
-
Removal of cell surface heparan sulfate increases TACE activity and cleavage of ErbB4 receptor
by: Tuittila Minna T, et al.
Published: (2009-01-01) -
Proteolytic processing of ErbB4 in breast cancer.
by: Maija Hollmén, et al.
Published: (2012-01-01) -
Analysis of ErbB Receptors: Regulation of ErbB-1 Kinase Activation and Localization of ErbB-4 to Membrane Microdomains
by: Thiel, Kristina Wyatt
Published: (2007) -
Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.
by: Guangyuan Li, et al.
Published: (2014-01-01) -
ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.
by: Diego Alvarado, et al.
Published: (2017-01-01)